Skip to content

A study of the central mechanism of acupuncture in the treatment of cough variant asthma

A study of the central mechanism of acupuncture in the treatment of cough variant asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000247
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough-variant asthma

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with cough-variant asthma (all 5 of the following are eligible for inclusion in the study): 1) Meet the diagnostic criteria for CVA; 2) Age 18-60 years old; gender is not limited; right-handed; 3) Regular application of antiasthmatic therapeutic drugs (mainly bronchodilators and [or] glucocorticoids) for at least 4 weeks without complete symptomatic relief with a cough severity VAS score value of >30 mm; 4) Voluntarily participate in this trial and sign the informed consent; 5) No contraindications to NMR scanning such as metals in the body. Healthy volunteers (all 4 of the following can be included in the study): 1) People aged 40 years = age = 80 years male or female right-handed; 2) The lung function test is not abnormal and the ability of daily life is normal; 3) No contraindications for nuclear magnetic scanning such as metals in the body; 4) Have good compliance voluntary co-operation with the study and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients meeting any 1 of the following were excluded: 1) Have a history of or been experiencing acute respiratory infections in the last 2 weeks such as colds/ pneumonia/ active tuberculosis; 2) Combined typical asthma COPD and other respiratory diseases that have symptoms such as shortness of breath in addition to cough as the main complaint; 3) Have infection or other focal injury multiple infarcts or infarcts located in areas of the cognitive control network or severe cerebral white matter lesions (Fazekas score =3) as suggested by MRI of the brain; 4) Have cancer mental illness cognitive dysfunction and hearing impairment that prevents normal communication; 5) Suffer from local skin lesions at acupoints such as burns/eczema/ ulcers/ frostbite breakouts/ coagulation disorders; 6) Women who are breastfeeding pregnant or preparing for pregnancy; 7) Patients within the last six months or who are participating in other clinical studies. Healthy volunteers (excluded if any 1 of the following is met): 1) People with claustrophobia; 2) Severe cranial anatomical asymmetry or definite lesions detected in the MRI scan; 3) Those who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Response rate;

Secondary

MeasureTime frame
Cough evaluation test;Coughing frequency in 24h;Leicester cough questionnaire;Cough hypersensitivity questionnaire;Hamilton anxiety scale;Cough severity dairy;Peripheral blood eosinophil counts;Pittsburgh sleep quality index;Fractional exhaled nitric oxide;Hamilton depression scale;

Countries

the People's Republic of China

Contacts

Public ContactLiang Fanrong

Chengdu University of Traditional Chinese Medicine

acuresearch@126.com13608058216

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026